Stallergenes gains U.S. FDA approval for Oralair allergy drug
April 01, 2014 at 19:27 PM EDT
April 1 (Reuters) - France's Stallergenes said on Tuesday it received the U.S. Food and Drug Administration's green light to sell its immunotherapy pill Oralair for treating grass allergies.